To address the question of whether established or experimental anticancer chemotherapeutics can exert their cytotoxic effects by autophagy, we performed a highcontent screen on a set of cytotoxic agents. We simultaneously determined parameters of autophagy, apoptosis and necrosis on cells exposed to B1400 compounds. Many agents induced a 'pure' autophagic, apoptotic or necrotic phenotype, whereas less than 100 simultaneously induced autophagy, apoptosis and necrosis. A systematic analysis of the autophagic flux induced by the most potent 80 inducers of GFP-LC3 puncta among the NCI panel agents showed that 59 among them truly induced autophagy. The remaining 21 compounds were potent inducers of apoptosis or necrosis, yet failed to stimulate an autophagic flux, which were characterized as microtubule inhibitors. Knockdown of ATG7 was efficient in preventing GFP-LC3 puncta, yet failed to attenuate cell death by the agents that induce GFP-LC3 puncta. Thus there is not a single compound that would induce cell death by autophagy in our screening, underscoring the idea that cell death is rarely, if ever, executed by autophagy in human cells.
Introduction
Cell death occurs through at least three morphologically distinct subroutines that have been named 'apoptosis', 'autophagic cell death' (ACD) and 'necrosis' (Edinger and Thompson, 2004; Kroemer et al., 2009) . Apoptosis is morphologically defined by nuclear shrinkage and fragmentation (Kerr et al., 1972) , whereas necrosis is defined by early permeabilization of the plasma membrane (Golstein and Kroemer, 2007; Degterev and Yuan, 2008) . By definition, ACD is characterized by massive sequestration of portions of the cytoplasm within autophagosomes, giving the cell a characteristic vacuolated aspect (Shintani and Klionsky, 2004; Tsujimoto and Shimizu, 2005) . Autophagosomes can be identified by transmission electron microscopy as twomembrane vesicles containing cytosol or cytoplasmic organelles. Autophagolysosomes, which arise from the fusion of autophagosomes and lysosomes, are delimited by one single membrane that contains degenerating organelles that are being degraded through the process that is referred to as macroautophagy (called 'authophagy' throughout this paper).
It is a methodological challenge to measure autophagy accurately Mizushima et al., 2010) . Beyond ultrastructural analyses, one of the most effective methods to detect autophagosomes and autophagolysosomes consists of the transfection-enforced expression of a green fluorescent protein (GFP)-LC3 fusion protein that decorates the membranes of autophago(lyso)somes, both in vivo, in animals , or in vitro, in cultured cells (Kabeya et al., 2000) , including in high-content screens (Zhang et al., 2007; Lipinski et al., 2010) . GFP-LC3 usually distributes diffusely throughout cells, yet accumulates in so-called 'autophagic puncta' (Kabeya et al., 2000) in the cytoplasm of cells when autophagy is induced. Autophagosomes are formed and destroyed continuously, establishing the autophagic flux (Mizushima et al., 2010) . As a result there are two reasons why autophagosomes (that are detected as GFP-LC3 puncta) can increase in number: (i) an increase in the on-rate, that is, the autophagic sequestration of cytoplasmic material and (ii) a decrease in the off-rate, for instance, as a result of reduced fusion between autophagosomes and lysosomes (Yu et al., 2010) . To accurately distinguish between these two possibilities, it is possible to stop the fusion between autophagosomes and lysosomes, for instance, by adding the vacuolar ATPase inhibitor bafilomycin-A1 (BafA1) (Mizushima et al., 2010) . If a particular culture condition, pharmacological agent or genetic manipulation increases the frequency of GFP-LC3 puncta even in the presence of BafA1, it can be concluded that it enhances the on-rate of autophagy.
However, if such a condition or agent induces GFP-LC3 puncta over the level of untreated controls, yet fails to further increase GFP-LC3 in the presence of BafA1 above the value observed with BafA1 alone, it merely reduces the off-rate of autophagy (Mizushima et al., 2010) .
Although expression ACD is a linguistic invitation to believe that cell death is executed by autophagy , accumulating evidence indicates that ACD is a variant of cell death that occurs with autophagy yet is not mediated by autophagy, at least in mammalian cells (Akdemir et al., 2006; Kroemer and Levine, 2008) . Indeed, there are no or few convincing examples in which specific inhibition of autophagy by knockout or knockdown of essential autophagy-relevant genes (the ATG gene) would fully inhibit cell death induced by specific stressors or pharmacological agents (Shimizu et al., 2004 (Shimizu et al., , 2010 Berry and Baehrecke, 2007; Samara et al., 2008; Turcotte et al., 2008) . Rather, autophagy is usually a self-limited process that protects cells from death by multiple mechanisms, including improved maintenance of bioenergetic homeostasis, recycling of misfolded and aggregate prone proteins, and removal of damaged organelles such as uncoupled or permeabilized mitochondria Mizushima et al., 2008) . In addition, it is plausible that liberation of Bcl-2 and FLIP from activated autophagy protein complexes may free these molecules to block the intrinsic and extrinsic pathways of apoptosis, respectively (Pattingre et al., 2005; Maiuri et al., 2007; Lee et al., 2009) . Although there is an abundant literature suggesting that autophagy and apoptosis are mutually exclusive (for Systematic study of autophagy, apoptosis, necrosis S Shen et al instance because calpains and caspases destroy specific ATG gene products) (Xia et al., 2010) , little is known about the functional relationship between autophagy and necrosis.
Although doubts have been shed on the existence of 'true' ACD (that is cell death executed by autophagy) in the mammalian system , there are a few examples of cell death in model organisms that can be largely prevented by genetic inhibition of autophagy. This applies to the developmental cell death of salivary gland cells in Drosophila larvae (Berry and Baehrecke, 2007) . Moreover, the excitotoxic cell death of Caenorhabditis elegans neurons, which is induced by the expression of constitutively active ion channels, can be avoided by knocking down various ATG genes (Samara et al., 2008) .
Given the fact that model organisms have paved the way to the exploration of mammalian cell death in several instances (Golstein et al., 2003; Yuan and Horvitz, 2004; Carmona-Gutierrez and Madeo, 2006; Golstein and Kroemer, 2007; Steller, 2008) , we decided to re-investigate the possibility that autophagy might contribute to lethal self-destruction of mammalian cells, at least in some specific instances. As a result, we took advantage of a panel of cytotoxic compounds that have been collected because of their capacity to kill tumor cells and that are either in clinical use or under clinical investigation as anticancer agents (Monga and Sausville, 2002) . Using this mechanistic set of cytotoxic agents collected by the National Cancer Institute (NCI) we systematically addressed the functional and hierarchical relationship between autophagy, apoptosis and necrosis. Although numerous agents were highly efficient in inducing GFP-LC3 puncta, we were unable to isolate a single agent (among 897) that would kill cells by autophagy.
Results

A chemical compound screen for simultaneous detection of autophagy, apoptosis and necrosis
In an attempt to clarify the hierarchical relationship among different catabolic pathways, including autophagy, apoptosis and necrosis, we exposed U2OS cells that had been stably transduced with GFP-LC3 to 1377 different chemical compounds from the ICCB library of bioactive compounds (480 agents, concentration 3B12 mM) and the NCI mechanistic set library (897 small molecules, all used at 1 mM). After 24 h of culture in 96-well microtiter plates, the cells were stained with the vital dye propidium iodide (PI, red fluorescence), which only labels cells with a permeable plasma membrane, and with Hoechst-33342 (blue fluorescence), which labels chromatin and hence informs on nuclear morphology. Thereafter, cells were fixed with paraformaldehyde and subjected to robotized epifluorescence microscopy with quasi-confocal resolution, followed by automatic image analysis, normalization of inter-and intra-plate variations, and data analysis (Figure 1a) . Three parameters indicative of autophagy (GFP granularity reflecting a shift from the normally diffuse to a punctate pattern, GFP dot count and GFP dot area), three parameters indicative of apoptosis (Hoechst-33342 granularity reflecting compaction of chromatin in discrete areas of the nucleus, nuclear perimeter and the maximal diameter of the nucleus) and one parameter specific for necrosis (PI intensity) were calculated automatically and verified manually (Figure 1b) . While the parameters determined within each category showed a significant (Po0.001, Pearson calculation) correlation among each other (such as GFP dot count and GFP dot area, or Hoechst granularity and Hoechst perimeter), there was no significant (P40.05) correlation between parameters indicative of autophagy and parameters indicative of apoptosis or necrosis. By contrast, apoptosis and necrosis showed a significant (Po0.05) correlation, in line with the notion that many cytotoxic agents induce both apoptosis and primary necrosis or apoptosis followed by secondary necrosis.
Next, the 1377 agents used in this study were subjected to unsupervised hierarchical clustering according to the seven parameters of autophagy, apoptosis and necrosis that were measured ( Figure 2a ). This procedure led to the identification of several clusters of agents with defined properties. Cluster-I comprised agents that induced GFP-LC3 dots and increased nuclear size, likewise as a correlate of polyploidization. This cluster was enriched in topoisomerase-II inhibitors (Figure 2a Figure 1A) . The agents grouped in cluster-II stimulate GFP-LC3 puncta, yet did not induce apoptosis or necrosis ( Figure 2a ). These cluster-II agents were rather heterogeneous in their mode of action (Figure 2b ), yet enriched for ion channel inhibitors (Supplementary Figure 1B) . Cluster-III agents induced 'pure' apoptosis, whereas cluster-IV agent induced 'pure' necrosis (Supplementary Figures 1C and D) .
Cluster-V agents apparently induced GFP-LC3 puncta, apoptosis and necrosis simultaneously ( Figure 1a ). However, this cluster was highly enriched in microtubule inhibitors ( Figure 1b and Supplementary Figure  1E ), which are known to prevent fusion between autophagosomes and lysosomes (Webb et al., 2004; Shen et al., 2010) . Hence, these agents are unlikely to induce autophagic flux and rather prevent the turnover of autophagosomes (see below). Cluster-VI induced both apoptosis and necrosis without autophagy or mild inhibition of basal level of autophagy (Figures 1a and b and Supplementary Figure 1F ). These results suggest that each of the cell death modalities studied here can occur independently from each other, as well as in different combinations, without a preferential hierarchy of molecular events.
Quantification of autophagic flux induced by inducers of GFP-LC3 puncta within the NCI panel To further explore the impact of autophagy induction on the mode of action of cytotoxic agents from the NCI panel, we chose the 80 NCI compounds that most significantly (Po0.005) induced GFP-LC3 puncta at Systematic study of autophagy, apoptosis, necrosis S Shen et al Compounds in each specific cluster were projected onto self-organizing maps of the NCI software as described under section Materials and methods. Each red plot represents a clustering of compounds. GFP, green fluorescent protein; M, mitotic; N, membrane integrity; NCI, National Cancer Institute; P, phosphatase/kinase/cell cyle; S, nucleic acid synthesis-affecting. Q and R have currently not been assigned.
Systematic study of autophagy, apoptosis, necrosis S Shen et al a concentration of 1 mM, after 12 h of incubation ( Figure 3a ). This time point was chosen because most of the agents still lacked a major cytotoxic effect (not shown) yet induction of GFP-LC3 puncta was significantly higher than at 6 h ( Figure 3b ). All of the 80 compounds that induced GFP-LC3 puncta in U2OS sarcoma cells also did so in HeLa carcinoma cells, underscoring that they have broad activity (Figure 3c ). Systematic dose response studies allowed us to establish a hierarchy of potency among inducers of GFP-LC3 puncta (Figure 3d and Supplementary Table 1) . We chose to further characterize two agents that were highly potent in inducing GFP-LC3 puncta (in the top 20) and had not been reported previously to modulate autophagy. Amsacrine, a topoisomerase-II inhibitor that has been approved by the FDA for the treatment of acute myeloid leukemia (Arlin et al., 1992) , potently induced autophagic flux as indicated by its ability to reduce the abundance of the autophagic substrates p62 (Bjorkoy et al., 2009 ) (Supplementary Figure 2A) and a mutant (Q74) huntingtin protein (Korolchuk et al., 2009) fused to red fluorescent protein (RFP) (Supplementary Figure 2B ). Amsacrine also further increased GFP-LC3 puncta in the presence of BafA1 (Supplementary Figure 2C and D). By contrast, siomycin-A (which is a putative FoxM1 inhibitor) (Radhakrishnan et al., 2006) failed to induce autophagy and rather inhibited fusion between GFP-LC3 þ and LAMP2 þ vacuoles, indicating that it prevented the fusion between autophagosomes and lysosomes (which is also inhibited by the vacuolar ATPase inhibitor, BafA1) (Supplementary Figure 2A -D). These results underscore the necessity of carefully measuring autophagic flux to distinguish inducers of autophagy from blockers of the last steps of autophagic turnover. Driven by these considerations, we decided to systematically measure autophagic flux by incubating GFP-LC3-expressing cells with the 80 selected compounds of the NCI panel in the absence and presence of BafA1, followed by determination of GFP-LC3 puncta, nuclear shrinkage and plasma membrane permeabilization (Figures 4a-d) . Importantly, we could distinguish two clusters of agents. Twenty-one agents within cluster-A (red dots in Figure 4a ) induced a similar number of GFP-LC3 puncta per cell in the absence and presence of BafA1. These agents were highly potent in inducing apoptosis and necrosis, and their cytotoxic potential was not affected by BafA1 (Figures 4b and c) . By contrast, another cluster of agents, cluster-B (which comprises 59 of the 80 compound; blue squares in Figures 4a-c) induced more GFP-LC3 puncta in the presence of BafA1, indicating that they truly induced autophagic flux. These agents were poorly apoptogenic and poorly cytotoxic, and their mild cytotoxicity was abolished in the presence of BafA1 (Figure 4c ). This classification into the two clusters A þ B was identical when the agents were tested on U2OS sarcoma cells (Figure 4 ) and HeLa cells (Supplementary Figure 3) . Of note, amsacrine (which induces autophagic flux) fell into cluster-B, whereas siomycin-A (which blocks autophagic flux) fell into cluster-A, validating this classification. Furthermore, the agents found in cluster-A were overrepresented in cluster-V, that is, the series of agents that simultaneously induce GFP-LC3 puncta and provoke both apoptosis and necrosis. As in cluster-V, microtubule inhibitors were overrepresented in cluster-A (Figure 4e ). Although significant, these correlations were imperfect.
Mechanistic characterization of inducers of GFP-LC3 puncta from the NCI panel Next, we explored the physicochemical differences between compounds that induce (cluster-B) or block autophagic flux (cluster-A). Cluster-A compounds tended to have high (49) pKa values (and hence are mild acids), whereas the pKa values of cluster-B agents were distributed over a wide range (Figure 5a and  Supplementary Table 2 ). Moreover, cluster-A agents tended to be relatively lipophilic (with a higher partition in octanol than in water) than cluster-B (Figure 5b and  Supplementary Table 3) , although these significant (Po0.0001) differences did not allow to neatly separate the two clusters. Tanimoto similarity calculations failed to yield a clear correlation between chemical structures and the separation into two functional groups A and B (Figure 5c , Cluster-A, compounds indicated by red; Cluster-B, compounds indicated by blue). Based on the fact that several among cluster-A compounds (11 of 21) fell into the group of microtubule inhibitors ( Figure 4e ) and/or showed similar chemical structures (Figure 5c ), we investigated the microtubule-inhibitory activity of all 80 inducers of GFP-LC3 puncta. Of note, the microtubular network of human cancer cells was disrupted by all 21 compounds in cluster-A (including the 10 compounds for which such an action was unknown). By contrast, none of the 59 cluster-B compounds affected microtubules (Figure 5d ). Similarly, agents from cluster-A induced more eIF2a phosphorylation or stress Supplementary Table 1) . GFP, green fluorescent protein; NCI, National Cancer Institute.
Systematic study of autophagy, apoptosis, necrosis S Shen et al granules (G3BP-GFP), a sign of ER stress (Boyce et al., 2005) , than cluster-B compounds (Figure 5e and Supplementary Figure 4) . However, this difference was not clear enough to lead to a full separation of the two clusters. To conclude, microtubule inhibition defines cluster-A.
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Absence of autophagic cell death inducers from the NCI panel of cytotoxic anticancer agents
To investigate the contribution of autophagy to the cytotoxic action of agents that induce GFP-LC3 puncta in a direct manner, we transiently knocked down ATG7 (Supplementary Figure 5) using a specific small interfering RNA (siRNA). This siRNA reduced autophagy induction by all the tested agents (Figure 6a ). Although there was no clear effect of ATG7 depletion on nuclear apoptosis induced by the 80 compounds (Figure 6b ), we observed a significant pro-necrotic effect for most of the agents (Figure 6c ), as this was validated using cytofluorometric cell death measurements (Supplementary Figure 6) . Only one agent, the microtubule inhibitor colchicin, induced a lower percentage of PI þ cells in the absence of ATG7 than in its presence (Figure 6c ). However, this finding is likewise linked to the loss of mitosis-arrested cells that failed to be detected by microscopy (because they detach from the plastic substrate), and independent determinations performed by cytofluorometry showed that ATG7 knockdown (Figure 6e ) or Beclin-1 knockdown (Figure 6f ) failed to decrease cell death induction by colchicin. To conclude, it appears that none of the 80 compounds that we selected based on their capacity to induce GFP-LC3 puncta killed cells through induction of autophagy.
Discussion
Based on fragmentary evidence from our own laboratory Kroemer and Jaattela, 2005) as well as a growing body of literature (Degenhardt et al., 2006; Karantza-Wadsworth et al., 2007; Kroemer and Levine, 2008; Harhaji-Trajkovic et al., 2009; Moreau et al., 2010) , we postulated that autophagy is mostly a cytoprotective mechanism and that it rarely, if ever, constitutes a lethal effector mechanism that is responsible for cellular demise . Driven by the observation that in some specific cases of developmental cell deathfor instance in the context of salivary gland involution in Drosophila larvae-autophagy has been attributed a cell death-executing function (Lee and Baehrecke, 2001) , we decided to screen the entire mechanistic set of cytotoxic anticancer agents developed by the NCI for autophagic cell death inducers. Although a significant fraction of the compounds analyzed here, namely B80 of 897 (8.9%) induced a significant cytoplasmic accumulation of GFP-LC3 puncta, none of these agents actually killed cells through induction of autophagy.
Indeed, knockdown of ATG7 (or other ATG proteins, including Beclin-1) was efficient in reducing the number of GFP-LC3 puncta induced by these agents, yet completely failed to avoid the concomitant cell death induction. Only 21 among the 80 selected inducers of GFP-LC3 puncta were endowed with the capacity of inducing apoptosis and necrosis. Systematic analyses of the autophagic flux by comparison of drug effects in the absence and presence of BafA1 showed that these 21 cytotoxic compounds actually were unable to trigger the on-phase of autophagy and rather blocked the off-phase of autophagy. Although these 21 agents were heterogeneous in their physicochemical characteristics and molecular structures, all of them turned out to inhibit microtubules and hence interrupted the fusion between autophagosomes and lysosomes (Webb et al., 2004) . Thus, we failed in our attempt to identify agents that would kill cancer cells by inducing massive autophagy and rather confirmed that autophagy is a mostly cytoprotective mechanism. Importantly, all the agents that induced the on-phase of autophagy became more cytotoxic when autophagy was blocked by knocking down ATG7, yet lost their cytotoxic potential when the number of GFP-LC3 puncta was further enhanced by treatment with BafA1. This latter result indicates that the so-called 'frustrated autophagy' (in which the offphase of autophagy is blocked) does not increase the acute cytotoxic efficacy of anticancer agents, contrasting with observations on post-mitotic cells (Gottlieb and Mentzer, 2010) .
Increased autophagy is observed in transformed cells when exposed to diverse kinds of stress (Kroemer et al., 2010) . In this context, it is increasingly appreciated that autophagy confers cytoprotection to cancer cells that otherwise would succumb to adverse conditions, be it in the primary tumor microenvironment or during the phase of metastatic dissemination. For example, autophagy is often observed in the hypoxic core of tumors where it promotes survival (Degenhardt et al., 2006) , and hypoxia-inducible factor-1a is a positive regulator of autophagy (Bellot et al., 2009) . Autophagy is also crucial for the survival of dormant cells in an ovarian cancer model (Lu et al., 2008) . High levels of autophagy can also be observed in tumor cells following anticancer treatments. A number of distinct anti-neoplastic therapies, including radiation therapy, DNA-damaging agents (for example, doxorubicin, camptothecin), his- (Figure 2a) . BafA1, bafilomycin-A1; GFP, green fluorescent protein; PI, propidium iodide.
Systematic study of autophagy, apoptosis, necrosis S Shen et al tone deacetylase inhibitors and hormone antagonists (for example, tamoxifen), reportedly induce autophagy in various human cancer cells, highlighting the possibility of targeting autophagy as adjuvant therapy for cancer (Livesey et al., 2009 ). In our screening, an FDAapproved drug, amsacrine, which is a topoisomerase-II Systematic study of autophagy, apoptosis, necrosis S Shen et al Systematic study of autophagy, apoptosis, necrosis S Shen et al inhibitor, has been shown to induce a high level of autophagy. Amsacrine may activate ATM by inducing DNA damage, thereby activating the TSC2 tumor suppressor through the LKB1/AMP-activated protein kinase (AMPK) metabolic pathway and inducing autophagy (Alexander et al., 2010) . It will be interesting to evaluate the efficacy of anticancer therapies in which amsacrine is combined with autophagy inhibitors.
To conclude, a large collection of clinically used or experimental anticancer agents did not contain a single compound that would trigger cell death through induction of autophagy. These results allow us to generalize the postulate that, at least in human cancer therapy, autophagic cell death is unlikely to exist as a phenomenon in which cannibalistic destruction of cellular compounds explains the cell's demise.
Materials and methods
Cell lines and culture conditions
Unless otherwise indicated, the media and supplements for cell culture were purchased from Gibco-Invitrogen (Carlsbad, CA, USA). All cell lines were cultured at 37 1C under 5% CO 2 , in medium containing 10% fetal calf serum and 10 mM HEPES buffer. Dulbecco's modified Eagle's medium þ 1 mM sodium pyruvate was used for osteosarcoma U2OS cells and cervical carcinoma HeLa cells. To create a stable cell line expressing GFP-LC3, U2OS cells were transduced with pLenti6/V5-GFP-LC3 constructs, followed by selection with 0.8 mg/ml G418. HeLa cells were transfected with GFP-LC3 plasmid, followed by selection with 0.4 mg/ml G418.
High-content screen A total of 10 Â 10 3 U2OS cells stably expressing a GFP-LC3 chimera were seeded in 96-well imaging plates (BD Falcon, Sparks, NV, USA) 24 h before treatment. The cells were cultured in the presence of agents from the NCI mechanistic set library (897 compounds; concentration: 1 mM) and from the Institute of Chemistry and Cell Biology (ICCB, Harvard, MA, USA) known bioactive library (480 compounds; concentration range: 3B12 mM) under normal culture conditions for 24 h. Then the cells were fixed with 4% paraformaldehyde (Sigma, St Louis, MO, USA) and stained with 10 mg/ml Hoechst-33342 (Invitrogen) and 1 mg/ml propidium iodide (PI; Sigma). Images were acquired using a BD pathway 855 automated microscope (BD Imaging Systems, San Jose´, CA, USA) equipped with a robotized Twister II plate handler (Caliper Life Sciences, Hopkinton, MA, USA) using a Â 40 objective (Olympus, Center Valley, PA, USA) and further analyzed using the BD Attovision software (BD Imaging Systems) for Hoechst-33342-labeled nuclei and GFP-LC3 puncta in the cytoplasm (Criollo et al., 2010) . For the following re-screening of the NCI mechanistic set library, U2OS cells stably expressing GFP-LC3 were treated with the agents for 6 and/or 12 h and then fixed with 4% paraformaldehyde, followed by staining with Hoechst-33342 and PI. Images were acquired using the same procedures as mentioned above. For autophagy flux screening or ATG7 knockdown screening, U2OS cells stably expressing GFP-LC3 were treated with 5 ng/ml BafA1 for 1 h or reversetransfected with an ATG7 siRNA (GGAGUCACAGCU-CUUCCUU) for 48 h before addition of the 80 selected compounds, and then cells were fixed and stained with Hoechst-33342 and PI.
Phenotypic profiling and statistical analysis
We used the BD Attovision software for image processing. The images consisted of three channels (Green, GFP-LC3; Blue, Hoechst 33342; Red, PI). Nuclei were segmented by adaptive thresholding of the DNA channel and watershed segmentation. Cell boundaries were identified by dilation from the edge of the nuclei based on the whole-cell distribution of GFP-LC3. GFP-LC3 puncta were identified by means of the Round Ball 2 Â 2 algorithm followed by Top Hat segmentation, and only dots located in the cytoplasm were counted. Each cell was characterized by a set of seven morphological descriptors, computed on different channels, which consisted of GFP-LC3 granularity (cytoplasm), dot count, dot area, Hoechst-33342 granularity (nuclei), perimeter, major axis and PI intensity (nuclei). All descriptors were normalized by the B-score method using the R program (B-score ¼ r ip /MAD p , where r ip is the residual of the measurement for row i on the pth plate, which is obtained by fitting a two-way median polish; MAD p is the adjusted median absolute deviation of the pth plate). Then a correlation matrix was generated by means of the R program (Spearman rank correlation, Po0.001). Clustering analysis was performed using MultiExperiment Viewer (MeV version 4) (Saeed et al., 2003) . Hierarchical clustering was performed using Pearson uncentered correlation and average linkage. The list of the agents in the selected clusters (Cluster-I-Cluster-VI) was projected onto a self-organizing map from 3D MIND Drug Discovery and Data Mining Information for New Directions of the National Cancer Institute.
For the secondary screen of the NCI mechanistic set library, after B-score normalization, the data set was fitted to a theoretical probability density function using the R program and then P-values were calculated for each treatment. E-values and family-wise error rate (FWER) were calculated to control the occurrence of false positives. Compounds that caused significant deviation from the predicted underlying distribution function were designated active or significant. Eighty compounds were selected as autophagy inducers (Po0.005).
Cytofluorometry
The following fluorochromes were used to determined cell death-associated modifications: 3,3 0 -dihexyloxacarbocyanine iodide (DiOC 6 (3), 40 nM; Molecular Probes-Invitrogen, Eugene, OR, USA) for quantification of mitochondrial transmembrane potential (DC m ), and PI (1 mg/ml) to determine cell viability . After trypsinization, live cells were stained for 30 min at 37 1C, followed by cytofluorometric analysis using a FACS Vantage (Becton Dickinson, San Jose´, CA, USA).
Immunoblotting and immunofluorescence
Cells were lysed on ice in a buffer containing 1% NP-40, 20 mM HEPES (pH7.9), 10 mM KCl, 1 mM EDTA, 10% glycerol, 1 mM orthovanadate, 1 mM phenylmethylsulfonyl fluoride and a cocktail of protease inhibitors (Roche, Mannheim, Germany). Thereafter, total protein extracts were separated on precast NuPAGE Novex polyacrylamide gels (gradient 10% gels; Invitrogen) and subjected to standard immunoblotting protocols. To this aim, the following specific primary antibodies were used: anti-p62 (BD Sciences, San Jose´, CA, USA), anti-LC3 (Cell Signaling, Danvers, MA, USA), anti-ATG5 (MBL International, Woburn, MA, USA) and anti-ATG7 (Sigma). Blots were revealed with the appropriate horseradish peroxidase-labeled secondary antibodies (Southern Biotech, Birmingham, AL, USA) and the SuperSignal West Pico chemiluminiscence substrate (Pierce Biotechnology, Rockford, IL, USA). An anti-actin (AbCys, Paris, France) antibody was used to control equal loading.
For immunofluorescence studies, cells were fixed with paraformaldehyde (4% w/v in phosphate-buffered saline) followed by permeabilization using 1% Triton X-100 (Sigma) diluted in phosphate-buffered saline. The cells were stained with specific antibodies against Lamp2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or anti-S51-phosphorylated eIF2a (Cell Signaling), and nuclei were counterstained with 10 mg/ml Hoechst-33342 (Molecular Probes-Invitrogen). The primary antibodies were revealed with goat anti-rabbit IgG conjugated to Alexafluor-488 (green) or Alexafluor-568 (red) from Molecular Probes-Invitrogen. Fluorescence microscopy determinations were performed by means of a Leica IRE2 microscope equipped with a DC300F camera, and with an LSM 510 microscope (Carl Zeiss, Jena, Germany).
Chemoinformatics
Apparent pKa value for each compound was calculated using Advanced Chemistry Development/Physchem catch algorithm. Only pKa values corresponding to the dominant ionic form at pH 7.2 were reported here. Pairwise similarity values: 2D structure for each compound was first generated from the SMILE string file, and the pairwise similarity values were calculated based on the 2D structure. When a salt was present, it was first removed before calculating the chemical fingerprint of the parent molecule using the MDL Public keys. As compounds NSC 116693 and NSC 645657 are mixtures of compounds, they have been removed from the similarity analyses. Then Tanimoto coefficients were evaluated for all remaining pairs of molecules. All these calculations were performed using the Pipeline Pilot software. For the classification tree, molecular descriptors were calculated for each parent compound and were used to build a classification tree using the Molecular Operating Environment (MOE). Details about the three descriptors used in the classification tree are as follows: logP (o/w), logarithm of the octanol/water partition coefficient; logs, logarithm of solubility in water; a_acc, number of hydrogen-bond acceptor atoms.
